MedicQuant, a spin-off from Aarhus University established in 2019, is rooted in cutting-edge biosensor research conducted at the Gothelf Lab at iNANO. Our mission is to redefine the standard for small molecule diagnostics, with a particular emphasis on enhancing stroke patient management. The core of this project is the innovation and automation of our production platform to boost performance and ensure long-term stability.

CO:PLI effektiviserer og forenkler udviklingen af markedsførings- og brandingmateriale for virksomheder i industrier med strenge regulatoriske krav Vores AI-platform identificerer automatisk potentielle compliance-problemer, så brugerne kan iterere hurtigere og træffe bedre beslutninger. Forestil dig en fødevarevirksomhed, der arbejder på materiale til et nyt produkt eller content til deres hjemmeside. Ved at benytte CO:PLI kan de fra starten identificere potentielle compliance-problemer, spare tid, og sikre at de overholder regulatoriske krav. CO:PLI fungerer som en AI-assistent, der hjælper brugerne med at integrere compliance tidligt i deres projekter Med Innovationsfondens investering vil vi være i stand til at accelerere udviklingen af vores AI-platform, udvide vores rækkevidde inden for industrier med regulatoriske krav og hurtigere levere vores løsning til virksomheder, der har behov for vores produkt. Investeringen vil også hjælpe os med at indfri vores langsigtede vision: at blive en end-to-end content creation platform, der bruger AI til at hjælpe virksomheder i alle faser af udviklingsprocessen. CO:PLI har potentialet til at revolutionere virksomheders navigation i regulatoriske landskaber og frigøre mere tid til udvikling og innovation. CO:PLI vil også bidrage til at skabe et mere transparent og tillidsfuldt erhvervsliv, som gavner hele samfundet. Teamet bag CO:PLI har erfaring fra produktion af medicinsk AI udstyr, advokatbranchen og konsulentbranchen

Hydrogen is envisioned to become a key enabler and energy carrier in the future 100% renewable energy system with predicted applications within transportation, grid stability, industry, re-electrification, etc. The current Low-Cost Hydrogen project (LC-H2) has a game changing, break-through potential in the field of green hydrogen accelerating the entire PtX market. The project aims to validate/demonstrate electrolyser current density of 400 mA/cm2@1.6V and improve the efficiency of Alkaline Water Electrolyser (AWE) cell from today state-of-the-art of 63% energy conversion efficiency to 77% by combining different electrode/bipolar plate inventions in an optimised MW electrolyser configuration. The new inventions will make it possible to double the current density from 200mA/cm2 to 400mA/cm2 for the stack and thereby reduce the electrolyser stack CAPEX by a factor of two. Modelling technique and neutron imaging will be used for eliminating inflow/outflow bottlenecks in the cell supporting further optimisation of the cell efficiency – especially at high current densities. In short, the LC-H2 project will make improvements to the key components of the alkaline electrolysed stack for green hydrogen to be able to compete with hydrogen from fossil sources and thereby pave the way for a society based on 100% renewable energy.